Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Bliss GVS International PTE Ltd , Singapore, a wholly owned subsidiary of Bliss GVS Pharma Limited ( the Company ), has incorporated a wholly owned subsidiary namely THERALIFE PHARMA RDC PRIVATE LIMITED , Kinshasa Gombe, Democratic Republic of the Congo'.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the exchange that its Singapore-based wholly owned subsidiary, Bliss GVS International PTE Ltd, has incorporated a new wholly owned subsidiary named Theralife Pharma RDC Private Limited in Kinshasa Gombe, Democratic Republic of the Congo. The new entity is fully owned through the Singapore subsidiary, maintaining a three-tier ownership structure. The company has not disclosed any financial details, capital commitment, or business purpose for the new subsidiary. This is a routine corporate restructuring move under SEBI's Listing Obligations and Disclosure Requirements.
Neutral to mildly positive — the move signals international expansion into the African market, but with no disclosed investment size or business plan, the immediate impact on shareholders or the stock price is likely minimal.